First Trust Nasdaq Pharmaceuticals ETF (FTXH) |
| 42 -0.259 (-0.61%) 08-27 16:00 |
| Open: | 41.91 |
| High: | 42.14 |
| Low: | 41.8301 |
| Volume: | 325,765 |
| Market Cap: | 1,039(M) |
| PE Ratio: | 29.13 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 50.07 |
| Resistance 1: | 42.87 |
| Pivot price: | 41.06 |
| Support 1: | 40.12 |
| Support 2: | 38.42 |
| 52w High: | 42.87 |
| 52w Low: | 27.3 |
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 06 Aug 2026
Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now? - Yahoo Finance
Thu, 30 Jul 2026
Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)? - Yahoo Finance
Sun, 28 Sep 2025
First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) - intelligentinvestor.com.au
Thu, 17 Jul 2025
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - Yahoo Finance
Wed, 17 Apr 2024
The 5 Best Pharmaceutical ETFs of 2023 - ETF.com
Thu, 07 Mar 2024
EDGAR Filing Documents for 0001445546-22-005243 - SEC.gov
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
